CHROMATOGRAPHY MARKET ANALYSIS

Chromatography Market Size and Trends

Global chromatography market is estimated to be valued at USD 10.00 Bn in 2025 and is expected to reach USD 14.37 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

To learn more about this report, Request sample copy

Chromatography is used in various industries such as pharmaceuticals, food and beverage testing, academics institutes, and others. The market growth can be driven by increasing R&D investment in drug discovery by pharmaceutical companies. Growing concerns about food safety and increasing adoption of chromatography technique in proteomics and genomics research boosts demand for chromatography systems. Furthermore, technological advancements leading to miniaturization and automation of chromatography systems along with growing emphasis on analytical testing in industries like pharmaceuticals, biotechnology, and food and beverage can offer opportunities for the market players.

Increasing R&D investments in pharmaceutical and biotechnology industries

The pharmaceutical and biotechnology industries  have increased their research and development investments in recent years, and this drives the global chromatography market growth. These industries heavily rely on chromatography techniques for drug discovery, development and purification processes. Chromatography allows them to efficiently separate, identify and purify biomolecules and chemicals, which is crucial for bringing new drugs to the market. According to the report published by OECD, the top 10 pharmaceutical companies spent over US$ 200 billion combined on R&D activities in 2021, indicating an increase of 15% as compared to 2020. These companies are aggressively working on developing advanced therapies like gene therapies, monoclonal antibodies and other targeted therapies to treat chronic and complex diseases. Chromatography plays a vital role right from the initial research and clinical trial stages to the final commercial manufacturing of such complex biologic’s drugs. There has been also huge demand for powerful analytical tools like liquid chromatography-mass spectrometry to support quality control testing requirements. For instance, in January 2025, ICON plc, a healthcare intelligence and clinical research organization, launched a whitepaper on optimizing biotech funding, highlighting trends in R&D strategies among biotech firms. A survey showed 60% plan to increase R&D spending, with clinical trials cited as a major challenge.